These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3029793)

  • 1. Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.
    Steinfels GF; Tam SW; Cook L
    Psychopharmacology (Berl); 1987; 91(1):5-9. PubMed ID: 3029793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
    Balster RL
    J Pharmacol Exp Ther; 1989 Jun; 249(3):749-56. PubMed ID: 2471825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of the PCP/sigma-ligand (+)-N-allylnormetazocine in monkeys.
    Holtzman SG
    Pharmacol Biochem Behav; 1993 Feb; 44(2):349-55. PubMed ID: 8446667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phencyclidine-like discriminative stimuli of (+)- and (-)-N-allylnormetazocine in rats.
    Shannon HE
    Eur J Pharmacol; 1982 Oct; 84(3-4):225-8. PubMed ID: 7173321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine [(+)-3-PPP] but not (-)-3-PPP produces (+)-N-allylnormetazocine-like (SKF 10,047) discriminative stimuli.
    Steinfels GF; Tam SW; Cook L
    Life Sci; 1986 Dec; 39(26):2611-5. PubMed ID: 3796207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
    Slifer BL; Dykstra LA
    Life Sci; 1987 Jan; 40(4):343-9. PubMed ID: 3027481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds.
    Picker MJ
    Behav Pharmacol; 1991 Dec; 2(6):497-511. PubMed ID: 11224092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors.
    Zukin SR; Brady KT; Slifer BL; Balster RL
    Brain Res; 1984 Feb; 294(1):174-7. PubMed ID: 6199090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR; Katzen JS; Woods JA; Tripathi HL; Harris LS; May EL
    J Pharmacol Exp Ther; 1984 Dec; 231(3):539-44. PubMed ID: 6094791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of sigma and phencyclidine receptor ligands on learning.
    Jones KW; Bauerle LM; DeNoble VJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):97-102. PubMed ID: 2163853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine.
    Steinfels GF; Alberici GP; Tam SW; Cook L
    Neuropsychopharmacology; 1988 Dec; 1(4):321-7. PubMed ID: 2855202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution.
    Compton DR; Bagley RB; Katzen JS; Martin BR
    Life Sci; 1987 Jun; 40(22):2195-206. PubMed ID: 3035304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y; Hiller JM; Simon EJ
    Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine.
    Tricklebank MD; Singh L; Oles RJ; Wong EH; Iversen SD
    Eur J Pharmacol; 1987 Sep; 141(3):497-501. PubMed ID: 2822452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sigma receptor ligands on schedule-controlled behavior of rats: relation to sigma and PCP receptor binding affinity.
    Wettstein JG; Roman FJ; Rocher MN; Junien JL
    Psychopharmacology (Berl); 1991; 104(2):157-63. PubMed ID: 1652142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.
    Halberstadt AL; Hyun J; Ruderman MA; Powell SB
    Pharmacol Biochem Behav; 2016 Sep; 148():69-75. PubMed ID: 27236030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding of [3H]d-N-allylnormetazocine and [3H]haloperidol to sigma receptors in the mouse brain.
    Weissman AD; Broussolle EP; London ED
    J Chem Neuroanat; 1990; 3(5):347-54. PubMed ID: 2171560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors.
    Carroll FI; Abraham P; Parham K; Bai X; Zhang X; Brine GA; Mascarella SW; Martin BR; May EL; Sauss C
    J Med Chem; 1992 Jul; 35(15):2812-8. PubMed ID: 1322987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-3-PPP antagonizes the discriminative stimulus effects of (+)-N-allylnormetazocine.
    Balster RL
    Eur J Pharmacol; 1986 Aug; 127(3):283-6. PubMed ID: 3019734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.